NeoVax Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

NeoVax General Information


Developer of vaccines. The company is engaged in developing vaccines for several infectious diseases including H5N1 influenza virus.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 6812 Idylwild
  • Boulder, CO 80301
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoVax Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeoVax‘s full profile, request access.

Request a free trial

NeoVax Executive Team (1)

Name Title Board Seat Contact Info
Jose Sandoval President
To view NeoVax’s complete executive team members history, request access »